Portada de Bad Blood

Bad Blood

The Theranos Story, From Boom to Bust

John Carreyrou

339 páginas2019PicadorInglésTapa blandaprinting (2)

Esta parte de readmunity es para lectores con cuenta.

Con una cuenta gratuita puedes guardarlo en tu biblioteca, valorarlo y reseñarlo.

Sinopsis(en Inglés)

No tenemos la sinopsis en tu idioma: se muestra la de la edición original.

Winner of the Financial Times/McKinsey Business Book of the Year Award 2018 The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

Citas

Todavía nadie ha guardado citas de este libro. Añádelo a tu biblioteca y podrás apuntar aquí los pasajes que quieras recordar.

Reseñas

Todavía no hay reseñas de este libro.

Te puede interesar · No ficción

Ver todos

Otras ediciones

  • inglésPicadorISBN 97815098680872019
  • inglésPan MacmillanISBN 97810350067792022
  • inglésAlfred A. KnopfISBN 97815247316562019
  • inglésAlfred A. KnopfISBN 97815247316632018
ISBN 9781509868087Metadatos: Metadatos abiertos (Open Library, CC0/PD) · registro de origen